Literature DB >> 12579387

[Manual medicine in chronic pain -- evaluation of an inpatient medical concept].

E Pioch1, W Seidel.   

Abstract

OBJECTIVE: The influence of an inpatient manual medical concept for patients suffering from chronic muscular skeletal pain syndromes on the quality of life and on target parameters of a biopsychological and social concept of pain (VAS, PDI, CES-D) was investigated. Furthermore, it was looked at the predictability of treatment outcome according to the Mainz Pain Stages.
METHOD: 211 patients of the Clinic for Manual Medicine were included in the study. Selected parameters such as pain intensity (VAS), pain distribution, disability in daily life (PDI), quality of life (SF-36) and grade of depression (CES-D) were evaluated on admission, discharge and 6 weeks after treatment. The patients were divided into groups according to the Mainz Pain Stages and compared to patients on the hospital waiting list (control group).
RESULTS: The patients were well distributed within the Mainz Pain Stages. It was shown that the manual therapy concept influenced different parameters dependent on the Main Pain Stages.For Stage 1 and 2 the deduction in pain intensity was greatest, while for stage 3 the reduction in disability (PDI) was the most significant outcome.
CONCLUSION: The therapeutic target should depend on the chronicity of the pain syndrome. Early interdisciplinary intervention, especially after increase in pain distribution is necessary to minimize chronicity. The Mainz Pain Stages are useful for the prediction of treatment outcome but still need further investigation for this group of patients.

Entities:  

Mesh:

Year:  2003        PMID: 12579387     DOI: 10.1007/s00482-002-0175-9

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  9 in total

1.  [Study on epidural steroid injection].

Authors:  K Niemier; M Schindler; T Volk; K Baum; B Wolf; J Eberitsch; W Seidel
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

2.  [Success of treatment in higher stages of pain chronification as well? An evaluation of the Mainz pain staging system based on the QUAST-analysis sample].

Authors:  M Hüppe; C Maier; H Gockel; M Zenz; J Frettlöh
Journal:  Schmerz       Date:  2011-02       Impact factor: 1.107

3.  [Efficacy of epidural steroid injections for chronic lumbar pain syndromes without neurological deficits. A randomized, double blind study as part of a multimodal treatment concept].

Authors:  K Niemier; M Schindler; T Volk; K Baum; B Wolf; J Eberitsch; W Seidel
Journal:  Schmerz       Date:  2015-07       Impact factor: 1.107

4.  [The influence of somatic dysfunction on chronic muscular skeletal pain syndromes].

Authors:  K Niemier; W Ritz; W Seidel
Journal:  Schmerz       Date:  2007-04       Impact factor: 1.107

5.  [Long-term effects of interventional treatment on chronic pain of the musculoskeletal system. Retrospective outcome study of repeated in-patient treatment].

Authors:  K Niemier
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

Review 6.  Back pain treatment: a new perspective.

Authors:  Anke Steinmetz
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-07-04       Impact factor: 3.625

7.  [Pain staging, gender, and rehabilitation outcome in chronic low back pain. A pilot study].

Authors:  P Hampel; A Brunnberg; B Krohn-Grimberghe; F Mantel; M Thomsen; A Hoischen; M Hrkac; L Tlach; M Morfeld; B Mohr
Journal:  Orthopade       Date:  2009-08       Impact factor: 1.087

8.  [Staging of pain in patients with chronic low back pain in inpatient rehabilitation: validity of the Mainz Pain Staging System of pain chronification].

Authors:  P Hampel; M F Moergel
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

9.  [Pain treatment facilities in Germany. Ambulatory, day care and inpatient facilities for patients with chronic pain].

Authors:  G Lindena; J Hildebrandt; H C Diener; P Schöps; C Maier
Journal:  Schmerz       Date:  2004-02       Impact factor: 1.107

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.